Full Press Release Details
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors.
CRVO
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
Key Takeaway: CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
Price reaction · baseline $19.62 (2024-03-27 close) · hit after-hours · 1 other CRVO headline(s) in the window, move may be shared
day 0 close · peak
+18.8%
day 1
+15.7%
day 3
+7.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
6.8%
average across 6 past catalysts
Cash runway
~10 mo
Medium dilution risk
Lead asset
Neflamapimod
Phase 2 · Moderate to Severe Acute Ischaemic Stroke